{"id":158037,"date":"2025-06-07T02:56:13","date_gmt":"2025-06-07T02:56:13","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/158037\/"},"modified":"2025-06-07T02:56:13","modified_gmt":"2025-06-07T02:56:13","slug":"un-traitement-plus-adapte-quand-la-tumeur-devient-resistante","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/158037\/","title":{"rendered":"un traitement plus adapt\u00e9 quand la tumeur devient r\u00e9sistante"},"content":{"rendered":"

Une nouvelle mol\u00e9cule offre de r\u00e9els espoirs pour les malades atteintes d\u2019un cancer du sein m\u00e9tastas\u00e9, selon une \u00e9tude pr\u00e9sent\u00e9e au congr\u00e8s annuel d\u2019oncologie \u00e0 Chicago. Une simple prise de sang permet de d\u00e9busquer de fa\u00e7on tr\u00e8s pr\u00e9coce la progression des tumeurs, et les bloquer.<\/p>\n

Agir au plus vite pour emp\u00eacher la progression d\u2019un cancer. L\u2019id\u00e9e para\u00eet simple, l\u2019enjeu n\u2019en est pas moins primordial. L\u2019\u00e9tude Serena-6, pr\u00e9sent\u00e9e dimanche dernier en s\u00e9ance pl\u00e9ni\u00e8re du congr\u00e8s annuel de la soci\u00e9t\u00e9 am\u00e9ricaine d\u2019oncologie (ASCO) et publi\u00e9 dans la revue\u00a0New England Journal of Medicine<\/a> , montre que l\u2019adaptation pr\u00e9coce du traitement, gr\u00e2ce \u00e0 la d\u00e9tection par simple prise de sang de la progression des cancers du sein hormonod\u00e9pendants (appel\u00e9s RH+ HER2-) m\u00e9tastatiques, permet d\u2019am\u00e9liorer sensiblement la qualit\u00e9 de vie des malades. \u00ab\u00a0La preuve de concept a \u00e9t\u00e9 apport\u00e9e en 2022 avec la publication des r\u00e9sultats d\u2019une \u00e9tude appel\u00e9e Pada-1, explique Fran\u00e7ois-Cl\u00e9ment Bidard, oncologue m\u00e9dical \u00e0 l\u2019IHU Institut des cancers des femmes de l\u2019Institut Curie, et premier auteur de ces travaux. Nous avions d\u00e9montr\u00e9 qu\u2019il \u00e9tait possible de d\u00e9tecter dans le sang des traces d\u2019ADN circulant \u00e0 des phases pr\u00e9coces avant la progression de la maladie. Ici, nous montrons que la prise d\u2019un nouveau\u2026<\/p>\n

\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 85% \u00e0 d\u00e9couvrir.\n <\/p>\n

\"Le<\/p>\n

Vente Flash<\/p>\n

3,99\u20ac par mois pendant 12 mois. Sans engagement.<\/p>\n

\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"Une nouvelle mol\u00e9cule offre de r\u00e9els espoirs pour les malades atteintes d\u2019un cancer du sein m\u00e9tastas\u00e9, selon une…\n","protected":false},"author":2,"featured_media":158038,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[237,101,232,231,234,228,1011,27,72,239,230,238,226,224,225,233,229,236,235,71,227],"class_list":{"0":"post-158037","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite-sur-les-maladies","9":"tag-cancer","10":"tag-cardiologie","11":"tag-cerveau","12":"tag-diabete","13":"tag-diagnostic","14":"tag-fr","15":"tag-france","16":"tag-health","17":"tag-info-sur-les-maladies","18":"tag-infographie","19":"tag-information-sur-les-maladies","20":"tag-maladie","21":"tag-medecine","22":"tag-medicament","23":"tag-obesite","24":"tag-pathologie","25":"tag-pediatrie","26":"tag-psychiatrie","27":"tag-sante","28":"tag-traitement"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114639836586204527","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/158037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=158037"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/158037\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/158038"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=158037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=158037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=158037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}